GGII Is Teaching a Class on How to Start a Beverage Company. Look at Who Pays.

A company that makes hemp cigarettes is teaching a class on how to start a functional beverage brand. It calls itself an incubator. It offers a free 12-week course, a private advisory group, and a professionally written press release to anyone who shows up. The catch: this company is losing money, has barely enough cash to keep the lights on, and wants you to believe its real product is education.

The stock is GGII. You might know it as Green Globe International. The company rebranded to "Fast Moving Consumer Goods, Inc." in January 2026 and is trying to change its ticker to FMCG. The rebrand is not cosmetic. It is an attempt to change what investors see when they look at the company.

Here is what is actually happening.

A company that was in the hemp-cigarette business for several years — it got there through a reverse merger with Hempacco in 2021 — is now hosting weekly webinars for aspiring CPG founders. The courses cover formula development, co-packer selection, FDA compliance, supply chain logistics, and retail placement. The CEO, Sandro Piancone, leads them himself. Attendees get a free press release worth $1,000.

This looks like generosity. But look at who else is invited.

The announcements explicitly target "investors seeking nationwide distribution and direct-to-consumer growth." The webinars are not only for founders. They are for people who might buy shares. The education is the marketing channel.

Now look at the financials. GGII reported roughly $3.7 million in revenue for the last full fiscal year. It lost $1.9 million, a net profit margin of minus 72 percent. It had about $250,000 in cash against $2.2 million in debt. Its current ratio was 0.36. A ratio below 1 means the company owes more in the near term than it holds in liquid assets. At 0.36, it owes nearly three times what it can cover.

For perspective: a company with $3.7 million in revenue and $250,000 in cash is not an incubator with the resources to help brands scale. It is a company struggling to pay its own bills.

The SEC filing for fiscal 2024 identified material weaknesses in internal controls — the kind of finding that means auditors could not rely on the company's own systems to produce accurate financial statements. This is not an unusual disclosure among micro-cap OTC stocks, but it is worth knowing. You are being asked to trust a financial story from a company that cannot trust its own accounting systems.

So what is the actual business model? GGII says it will earn revenue through ownership stakes in incubated brands, commissions from their product sales, and exit strategies. It lists a few names: Calmara Beverages, The Eye Drink, Forza Bar. These are described as "incubated" brands that have achieved "RangeMe Verified Brand" status — which means they can be seen by retail buyers on a B2B platform. That is real. It is also a very early step. Getting listed on RangeMe is not the same as getting on shelves at Walmart. The company says verified brands receive up to seven times more views. More views is not the same as more revenue for GGII.

The more interesting question is what happens when a company with $250,000 in cash tries to build an infrastructure-heavy business. Incubating CPG brands requires manufacturing relationships, supply chain management, regulatory expertise, and distribution connections. GGII says it has a 50 percent stake in Lucky To Be Beverages, a white-label manufacturing joint venture, and a minority interest in Green Star Labs, which operates a 50,000-square-foot facility. These are real assets. But they are also the kind of assets that burn cash. A 50,000-square-foot facility is not a line item. It is rent, certifications, staff, insurance, and compliance.

The company also just spun off Hempacco in August 2026, separating the hemp business that was its historical revenue source. That leaves the "incubator" as the forward-facing story. Which means the company is asking investors to fund a pivot based on webinars, press releases, and relationships that have not yet produced reported revenue.

Here is the mechanism at work. The webinars teach founders how hard it is to build a CPG brand. They are right. Only about 5 percent of new CPG products survive their first retail cycle, according to the company's own materials. The startup cost is $15,000 to $75,000. The timeline is 6 to 18 months. The regulatory complexity is real. Every piece of information in those webinars makes the founder think: this is harder than I thought. I need a partner. The partner is GGII.

But the founder who needs a partner and the investor who watches the webinar are different people with different problems. The founder needs infrastructure GGII cannot afford to build. The investor needs a company that generates revenue, not one that generates webinars.

This is not to say the pivot is impossible. Some companies do transition from one business to another. The question is whether this company has the resources to make the transition while it is asking shareholders to fund it. A company with negative working capital, a negative current ratio, and material control weaknesses is not in a position to bet on a multi-year incubation model. It is in a position to try to survive the next quarter.

There is also the question of shares. GGII reported roughly 66.6 billion shares outstanding at one point, though that number may have been adjusted through the Hempacco spin-off. Different sources show different figures. The market cap has ranged from roughly $3.3 million to about $10 million, depending on which share count and price you use. At any of those numbers, the stock is a micro-cap OTC penny stock with extremely high volatility. Macroaxis, a financial data provider, described it as "way too risky" with a coefficient of variation of 219 — meaning the stock's price swings are 219 percent of its average price. That is the definition of a stock that moves on announcements, not fundamentals.

The webinars are one more announcement. They generate press releases, which generate attention, which generates trading volume. The cycle is self-reinforcing. But trading volume is not revenue.

What to watch if you are curious about this stock. Does the incubator model produce reported revenue that is material relative to the $3.7 million the company already earned? Not press releases. Not RangeMe verification. Not announcements about events with celebrities. Actual revenue from incubated brands on an income statement. And does the company have enough cash to reach that point? At $250,000 in cash, the runway is measured in weeks, not quarters. If the company raises capital, at what dilution? With 66 billion shares, even a modest raise dilutes existing shareholders severely.

The way to evaluate a company calling itself an incubator is not to count the webinars. It is to ask who pays and who gets diluted between now and the first dollar of new revenue.